SCHEMBL5089874

SCHEMBL5089874

CNC(=O)Cc1ccc(N)c(O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.58
KDM4E B2RXH2 3/20 0.58
MAPT P10636 3/20 0.58
POLB P06746 2/20 0.58
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
RAB9A P51151 1/20 0.58
ALDH1A1 P00352 3/20 0.49
GFER P55789 1/20 0.49
TRPV1 Q8NER1 1/20 0.43
PCNA P12004 1/20 0.43
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
TSHR P16473 2/20 0.42
ALOX15 P16050 2/20 0.42
CA2 P00918 3/20 0.42
CA1 P00915 2/20 0.42
LMNA P02545 2/20 0.42
RGS12 O14924 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10663556 0.86 GAA (0.47) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL29902856 0.86 GAA (0.47) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL14015924 0.84 MAPT (0.60) GAAKDM4EMAPTPOLBALDH1A1
SCHEMBL5088853 0.83 TRPV1 (0.51) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL5094906 0.82 GAA (0.49) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL8990620 0.81 PCNA (0.48) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL16042637 0.81 ALDH1A1 (0.41) GAAKDM4EMAPTKMT2AMEN1
SCHEMBL29809190 0.81 ALDH1A1 (0.41) GAAKDM4EMAPTKMT2AMEN1
SCHEMBL5089884 0.81 TRPV1 (0.59) GAAKDM4EMAPTPOLBKMT2A
SCHEMBL15887321 0.80 GAA (0.59) GAAKDM4EMAPTPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2008510738-A 2008-04-10 JP claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP claimed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US claimed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP disclosed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US disclosed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds KRT18, TYR, ALPG GAA 4376/4885KDM4E 586/4885MAPT 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.